相关实验视频

Updated: May 30, 2025

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
06:37

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Published on: September 15, 2023

522

一个全州范围的远程医疗推系统,用于区域单克隆抗体输液中心

Romeo R Fairley1, Andrew Ta1, Tatiana Emanuel1

  • 1University of Texas Health Science Center San Antonio, San Antonio, Texas, USA.

Telemedicine journal and e-health : the official journal of the American Telemedicine Association
|January 30, 2025
PubMed
概括

一个远程医疗推系统成功地将6000多名高风险的COVID-19患者与单克隆抗体输液连接起来. 这一系统显著改善了医疗服务不足地区的个人获得医疗服务的机会,使医院的医疗服务分散.

关键词:
在 COVID-19 疫情中,传染病是一种传染性疾病.医疗服务不足的人群这是一种单克隆抗体.公共卫生公共卫生.远程医疗服务是远程医疗服务.远程医疗远程医疗

更多相关视频

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens09:57

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens

Published on: February 14, 2011

11.9K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.2K

相关概念视频

Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.0K